Colorectal Cancer Diagnostics Market is expected to grow at 4.85% through 2030F

Advancement diagnostic procedures and rising awareness among individuals is expected to drive the growth of Global Colorectal Cancer Diagnostics Market during the forecast period.

According to TechSci Research report, “Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F,” Global Colorectal Cancer Diagnostics Market was valued at USD 18.05 billion in 2024 and is expected to reach USD 23.79 billion by 2030 with a CAGR of 4.85%.

Technological advancements in diagnostics are significantly transforming the global colorectal cancer diagnostics market. The integration of innovative tools and techniques has enhanced the accuracy, speed, and accessibility of colorectal cancer detection, supporting earlier diagnosis and improved patient outcomes. Traditional methods such as colonoscopy and biopsy remain critical, but emerging technologies are expanding the diagnostic landscape. High-definition endoscopy, capsule endoscopy, and virtual colonoscopy (CT colonography) are offering less invasive and more detailed visualization of the colon, enabling the detection of smaller or hard-to-reach lesions. These innovations are especially valuable in reducing patient discomfort and increasing screening compliance. Molecular diagnostics have also made substantial strides. Biomarker-based assays and next-generation sequencing (NGS) are enabling precise identification of genetic mutations and tumor markers associated with colorectal cancer. These tests support personalized medicine by guiding treatment decisions and monitoring disease progression or recurrence. Liquid biopsies—non-invasive blood tests that detect circulating tumor DNA (ctDNA)—are gaining traction as a promising alternative to traditional tissue biopsies. They allow for real-time disease monitoring with minimal patient burden, and their use is rapidly expanding in both screening and post-treatment surveillance.

Artificial intelligence (AI) and machine learning algorithms are being integrated into imaging and pathology workflows, improving diagnostic accuracy, reducing human error, and enabling faster analysis. These technologies are increasingly being adopted in clinical settings for risk stratification and early anomaly detection. Collectively, these technological advancements are reshaping the global colorectal cancer diagnostics market by offering more precise, efficient, and patient-centered solutions, thereby driving greater adoption and market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Colorectal Cancer Diagnostics Market"

Global Colorectal Cancer Diagnostics Market can be segmented into diagnosis type, application, region, and company.

Based on application, Hospitals and specialty clinics emerge as Fastest Growing Segment in the global colorectal cancer diagnostics market due to their comprehensive capabilities, advanced infrastructure, and access to specialized medical expertise. These healthcare settings are equipped with state-of-the-art diagnostic tools such as high-definition colonoscopy systems, imaging technologies, molecular testing platforms, and pathology labs, enabling accurate and timely diagnosis of colorectal cancer. The presence of trained gastroenterologists, oncologists, radiologists, and pathologists within these facilities ensures that patients receive expert evaluation and integrated care, from screening and diagnosis to treatment planning.

Hospitals and specialty clinics also serve as centralized hubs for multidisciplinary cancer care, offering coordinated services that improve patient outcomes. Their ability to perform invasive procedures, like biopsies and therapeutic colonoscopies, further strengthens their position in the market. These institutions often participate in national screening programs and awareness campaigns, increasing patient access to diagnostic services. Hospitals and specialty clinics generally have better reimbursement and funding mechanisms, making advanced diagnostics more accessible to patients. Collectively, these factors contribute to the dominance of hospitals and specialty clinics in the colorectal cancer diagnostics market, as they provide comprehensive, reliable, and efficient diagnostic solutions that are essential for effective disease management.

The leading companies operating in the Global Colorectal Cancer Diagnostics Market are:

·         Abbott Laboratories

·         Illumina, Inc.

·         Sysmex Corporation

·         Beckman Coulter

·         Siemens Healthineers AG

·         Quest Diagnostics

·         Danaher Corporation

·         Cancer Genetics Inc.

·         Biocept Inc.

·         Epigenomics AG

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global colorectal cancer diagnostics market is experiencing notable expansion in emerging markets, driven by increasing healthcare investments, growing awareness, and improving infrastructure. Countries in regions such as Asia-Pacific, Latin America, and parts of the Middle East and Africa are witnessing rising colorectal cancer incidence due to urbanization, changing lifestyles, and aging populations. This growing disease burden is prompting governments and private healthcare providers to focus on early detection and diagnosis, fueling demand for colorectal cancer diagnostic solutions”, said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.

“Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis Type (Diagnostics Imaging (Sigmoidoscopy, Colonoscopy, Others), Stool Test (Guaiac FOBT, Fecal immunochemical Test (FIT), FIT-DNA Test), Biopsy (Image Guided Biopsy, Liquid Biopsy, Others), Others), By Application (Hospitals & Specialty Clinics, Ambulatory Care Centers, and Others), By Region & Competition 2020-2030F”, has evaluated the future growth potential of Global Colorectal Cancer Diagnostics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Colorectal Cancer Diagnostics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com